Haemonetics Corp. (HAE) Tops Q3 EPS by 3c; Reaffirms Outlook
Get Alerts HAE Hot Sheet
Price: $119.65 -0.12%
Revenue Growth %: +5.6%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Revenue Growth %: +5.6%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q3 EPS of $0.50, $0.03 better than the analyst estimate of $0.47. Revenue for the quarter came in at $247.4 million versus the consensus estimate of $251.93 million.
Reaffirmed FY13 and FY14 guidance.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Reaffirmed FY13 and FY14 guidance.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Regal-Beloit (RBC) Tops Q3 EPS by 21c ; Offers Guidance
- Cboe Global Markets (CBOE) Tops Q3 EPS by 21c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share